Phase 1 dose-expansion study of pegylated arginine deiminase, cisplatin, and pemetrexed in patients with argininosuccinate synthetase 1 (ASS1)-deficient non-squamous non-small cell lung cancer.

被引：0
|
作者：
Wimalasingham, Akhila Ganeshi
Phillips, Melissa Mary
Lim, Louise
Rashid, Sukaina
Hall, Peter Edward
Khadeir, Ramsay
Steele, Jeremy P. C.
Conibear, John
Feng, Xiaoxing
Ellis, Stephen
Chan, Pui Ying
Thomson, Jim
Johnston, Amanda L.
Bomalaski, John S.
Pacey, Simon
Sheaff, Michael
Szlosarek, Peter Wojciech
机构：
[1] Barts Hlth NHS Trust, London, England
[2] Barts Canc Inst, London, England
[3] Queen Mary Univ London, London, England
[4] St Bartholomews Hosp, London, England
[5] Washington State Univ, Pullman, WA 99164 USA
[6] Barts Hlth Trust, London, England
[7] Polaris Pharmaceut Inc, San Diego, CA USA
[8] Agouron Pfizer, San Diego, CA USA
[9] Univ Cambridge, Cambridge, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9097
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Multicenter phase II study of cisplatin, pemetrexed, plus bevacizumab followed by maintenance pemetrexed plus bevacizumab for patients with advanced or recurrent non-squamous non-small cell lung cancer: MAP study
    Tsutani, Y.
    Miyata, Y.
    Masuda, T.
    Fujitaka, K.
    Doi, M.
    Awaya, Y.
    Kuyama, S.
    Kitaguchi, S.
    Ueda, K.
    Okada, M.
    ANNALS OF ONCOLOGY, 2017, 28 : 137 - 137
  • [42] EFFICIENCY OF CISPLATIN, PEMETREXED, AND BEVACIZUMAB AS FIRST-LINE TREATMENT FOR JAPANESE ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER PATIENTS
    Shiraishi, Yoshimasa
    Hirai, Humihiko
    Yamaguchi, Masafumi
    Morodomi, Yosuke
    Toyozawa, Ryo
    Inamasu, Eiko
    Kojo, Miyako
    Toyokawa, Gouji
    Takenaka, Tomoyoshi
    Seto, Takashi
    Takenoyama, Mitsuhiro
    Ichinose, Yukito
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S488 - S488
  • [43] Final overall survival analysis of phase III study of pemetrexed/cisplatin versus vinorelbine/cisplatin for completely resected non-squamous non-small cell lung cancer: The JIPANG Study
    Yoh, K.
    Kenmotsu, H.
    Yamamoto, N.
    Misumi, T.
    Takahashi, T.
    Saito, H.
    Sugawara, S.
    Yamazaki, K.
    Nakagawa, K.
    Sugio, K.
    Seto, T.
    Toyooka, S.
    Date, H.
    Mitsudomi, T.
    Okamoto, I.
    Yokoi, K.
    Saka, H.
    Okamoto, H.
    Takiguchi, Y.
    Tsuboi, M.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S972 - S973
  • [44] INDIRECT COMPARISON OF EFFICACY, SAFETY, AND COST: PEMETREXED/CISPLATIN VERSUS BEVACIZUMAB/GEMCITABINE/CISPLATIN IN PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER
    Orlando, Mauro
    Barraclough, Helen
    Orlov, Sergey
    Rajan, Narayan
    Davey, Peter
    Kanivets, Yana
    Han, Baoguang
    Brnabic, Alan
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1232 - S1233
  • [45] RETROSPECTIVE STUDY OF COMBINATION CHEMOTHERAPY WITH CISPLATIN PLUS PEMETREXED AS FIRST LINE THERAPY FOR ADVANCED NON-SMALL CELL NON-SQUAMOUS LUNG CANCER
    Inui, Toshiya
    Yokoyama, Takuma
    Takata, Saori
    Hirata, Aya
    Nishizawa, Tomotaka
    Hirukawa, Ichiro
    Wada, Hiroo
    Ishii, Haruyuki
    Takizawa, Hajime
    Goto, Hajime
    RESPIROLOGY, 2013, 18 : 149 - 149
  • [46] A phase II multicentre study of ziv-aflibercept in combination with cisplatin and pemetrexed in patients with previously untreated advanced/metastatic non-squamous non-small cell lung cancer
    Chen, H.
    Modiano, M. R.
    Neal, J. W.
    Brahmer, J. R.
    Rigas, J. R.
    Jotte, R. M.
    Leighl, N. B.
    Riess, J. W.
    Kuo, C. J.
    Liu, L.
    Gao, B.
    DiCioccio, A. T.
    Adjei, A. A.
    Wakelee, H. A.
    BRITISH JOURNAL OF CANCER, 2014, 110 (03) : 602 - 608
  • [47] A phase II multicentre study of ziv-aflibercept in combination with cisplatin and pemetrexed in patients with previously untreated advanced/metastatic non-squamous non-small cell lung cancer
    H Chen
    M R Modiano
    J W Neal
    J R Brahmer
    J R Rigas
    R M Jotte
    N B Leighl
    J W Riess
    C J Kuo
    L Liu
    B Gao
    A T DiCioccio
    A A Adjei
    H A Wakelee
    British Journal of Cancer, 2014, 110 : 602 - 608
  • [48] Phase II trial of induction chemotherapy of pemetrexed plus split-dose cisplatin followed by pemetrexed maintenance for previously untreated advanced non-squamous non-small cell lung cancer
    Uenami, T.
    Koba, T.
    Minami, S.
    Futami, Y.
    Masuhiro, K.
    Kimura, H.
    Futami, S.
    Yaga, M.
    Mori, M.
    Kagawa, H.
    Komo, S.
    Otsuka, T.
    Yamamoto, S.
    Komuta, K.
    Kijima, T.
    ANNALS OF ONCOLOGY, 2017, 28 : 141 - 141
  • [49] Prognostic value of Beclin 1, EGFR and ALK in non-squamous non-small cell lung cancer
    Yanhui Wan
    Youhui Qian
    Youyu Wang
    Fuyuan Fang
    Guodong Wu
    Discover Oncology, 13
  • [50] Prognostic value of Beclin 1, EGFR and ALK in non-squamous non-small cell lung cancer
    Wan, Yanhui
    Qian, Youhui
    Wang, Youyu
    Fang, Fuyuan
    Wu, Guodong
    DISCOVER ONCOLOGY, 2022, 13 (01)
12345